Cargando…

Implications of pseudogenes for the prognosis of hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Liu, Zaoqu, Zhang, Yuyuan, Weng, Siyuan, Xu, Hui, Han, Xinwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905005/ https://www.ncbi.nlm.nih.gov/pubmed/36750350 http://dx.doi.org/10.1002/ctm2.1195

Ejemplares similares

Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Epigenetically regulated gene expression profiles recognized three molecular classifications with prognostic and therapeutic implications in bladder cancer
por: Xu, Hui, et al.
Publicado: (2023)

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2023)

Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
por: Liu, Zaoqu, et al.
Publicado: (2021)

CircRNA-derived pseudogenes
por: Dong, Rui, et al.
Publicado: (2016)

Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options
por: Liu, Zaoqu, et al.
Publicado: (2022)

Comprehensive Molecular Analyses of a Six-Gene Signature for Predicting Late Recurrence of Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)

Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer
por: Weng, Siyuan, et al.
Publicado: (2023)

The importance of distinguishing pseudogenes from parental genes
por: Hesson, Luke B, et al.
Publicado: (2014)

Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

Integrative pharmacogenomics revealed three subtypes with different immune landscapes and specific therapeutic responses in lung adenocarcinoma
por: Ge, Xiaoyong, et al.
Publicado: (2022)

Editorial: Application of artificial intelligence in improving immunotherapeutic efficacy
por: Li, Jie, et al.
Publicado: (2022)

Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network
por: Yan, Lijun, et al.
Publicado: (2020)

ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
por: Xu, Hui, et al.
Publicado: (2022)

A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Gene Expression Profile Reveals a Prognostic Signature of Non–MSI-H/pMMR Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

The mir-767-105 cluster: a crucial factor related to the poor prognosis of hepatocellular carcinoma
por: Rui, Tao, et al.
Publicado: (2020)

Artificial intelligence‐driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi‐center integration analysis
por: Xu, Hui, et al.
Publicado: (2022)

A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinoma
por: Pan, Yun, et al.
Publicado: (2014)

Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma
por: Zhou, Xueliang, et al.
Publicado: (2021)

Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance
por: Ren, Yuqing, et al.
Publicado: (2023)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma
por: Wang, Libo, et al.
Publicado: (2023)

Reply to Gaudry et al.: Cross-validation is necessary for the identification of pseudogenes
por: Yuan, Yuan, et al.
Publicado: (2022)

Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis
por: Ren, Yuqing, et al.
Publicado: (2023)

New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma
por: Chen, Binghai, et al.
Publicado: (2018)

MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?
por: Li, Zhaonan, et al.
Publicado: (2021)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients
por: Tang, Shanshan, et al.
Publicado: (2021)

Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer
por: Wang, Libo, et al.
Publicado: (2022)

Octreotide and hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2007)

Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management
por: Liu, Zaoqu, et al.
Publicado: (2021)

Construction of a new immune‐related signature based on three lncRNAs as the factor for prognosis prediction of hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2020)

“One-stop” synergistic strategy for hepatocellular carcinoma postoperative recurrence
por: Liu, Yiming, et al.
Publicado: (2023)

Comment on: Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients
por: Akbulut, Sami, et al.
Publicado: (2021)

Construction of a diagnostic signature and immune landscape of pulmonary arterial hypertension
por: Duo, Mengjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s8tmkias6jbns00m5vshg6r0uo